Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 32188-75-3 | MDL No. : | MFCD05365582 |
Formula : | C12H13N3O2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | AFQKJSKHZCXGLQ-UHFFFAOYSA-N |
M.W : | 231.25 | Pubchem ID : | 4811199 |
Synonyms : |
|
Num. heavy atoms : | 17 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.42 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 69.43 |
TPSA : | 72.85 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | Yes |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.98 cm/s |
Log Po/w (iLOGP) : | 1.84 |
Log Po/w (XLOGP3) : | 2.44 |
Log Po/w (WLOGP) : | 2.08 |
Log Po/w (MLOGP) : | 0.83 |
Log Po/w (SILICOS-IT) : | 0.31 |
Consensus Log Po/w : | 1.5 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.94 |
Solubility : | 0.265 mg/ml ; 0.00115 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.61 |
Solubility : | 0.0564 mg/ml ; 0.000244 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -2.6 |
Solubility : | 0.586 mg/ml ; 0.00254 mol/l |
Class : | Soluble |
PAINS : | 1.0 alert |
Brenk : | 2.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.11 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
92% | for 0.5 h; | The compound 5-nitro-2- (piperidin-1-yl) benzoic acid was subjected to reduction reaction by NaBH4 for 30 min, followed by 2.0 g of a yellow solid (Compound 11) |
87% | With hydrogen In methanol for 16 h; | Step 2; 2-(1-piperidinyl)-5-(amino)benzonitrile; The 2-(1-piperidinyl)-5-(nitro)benzonitrile (25 g, 108 mmol) was solubilized in methanol (400 ml). A spatula tip of Pd/C was added to the mixture and the crude was stirred for 16 hours under hydrogen atmosphere. The mixture was filtered on Celite.(R)., concentrated and the expected product was isolated by recrystallization in an equimolar volume of dichloromethane and cyclohexane. Yield: 87percent |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
99% | With potassium carbonate In N,N-dimethyl-formamide at 90℃; for 3 h; | A mixture of 2-chloro-5-nitrobenzonitrile (2g,1 eq,10.96mmol), potassium carbonate (4.54g, 3eq, 32.7001), piperidine (1 · 63 mL, 1.5 eq, 16.34 mmol) and DMF (5 mL) at 90 ° C Should be 3h, until the reaction is complete, remove the oil bath. DMF was diluted with 100 mL EA, washed with saturated ammonium chloride and sodium chloride respectively. The aqueous phase was extracted again with ethyl acetate. The organic phases were combined and dried over anhydrous sodium sulfate. The filtrate was concentrated to give a yellow solid (Compound 10) 2.528 g, yield 99percent |
[ 451459-92-0 ]
2-(4-Methylpiperazin-1-yl)-5-nitrobenzonitrile
Similarity: 0.91
[ 451459-92-0 ]
2-(4-Methylpiperazin-1-yl)-5-nitrobenzonitrile
Similarity: 0.91
[ 30450-62-5 ]
7-Nitro-1,2,3,4-tetrahydroquinoline
Similarity: 0.78
[ 451459-92-0 ]
2-(4-Methylpiperazin-1-yl)-5-nitrobenzonitrile
Similarity: 0.91
[ 16155-08-1 ]
1-Benzyl-4-(4-nitrophenyl)piperazine
Similarity: 0.76
[ 5367-58-8 ]
5-Nitro-2-(piperidin-1-yl)aniline
Similarity: 0.71
[ 188604-99-1 ]
2-(4-Methylpiperidin-1-yl)-5-nitroaniline
Similarity: 0.70
[ 34595-33-0 ]
5-Amino-2-(piperidin-1-yl)benzonitrile
Similarity: 0.69
[ 5367-58-8 ]
5-Nitro-2-(piperidin-1-yl)aniline
Similarity: 0.71
[ 188604-99-1 ]
2-(4-Methylpiperidin-1-yl)-5-nitroaniline
Similarity: 0.70
[ 34595-33-0 ]
5-Amino-2-(piperidin-1-yl)benzonitrile
Similarity: 0.69
[ 166438-83-1 ]
(1-(4-Nitrophenyl)piperidin-3-yl)methanol
Similarity: 0.68